To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DDX11TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
268 supporting clones for gene DDX11 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC050522 Uterus, leiomyosarcoma .a 1 to 3749 3 to 3751 T575M tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3751/3751
(100 %)
2 diff
(100.0 %id)
BQ921461 leiomyosarcoma, uterus .a 1 to 831 2 to 834       834/872
(95 %)
9 diff
(99.0 %id)
CN260634 embryonic stem cells, cell lines H1, H7, andH9 .a 2755 to 3464 8 to 716   tiling clone,   709/716
(99 %)
7 diff
(99.1 %id)
AA730444 Ewing's sarcoma .a 2770 to 3179 29 to 438       410/438
(93 %)
6 diff
(98.7 %id)
AL135001 melanoma (MeWo cell line) .a 2772 to 3414 1 to 642       642/642
(100 %)
4 diff
(99.4 %id)
BG768874 melanotic melanoma, high MDR (cell line), skin .a 2820 to 3563 1 to 738       738/738
(100 %)
9 diff
(98.8 %id)
BX280645 melanotic melanoma, skin .a 2837 to 3315 5 to 483       479/483
(99 %)
6 diff
(98.8 %id)
BQ216498 melanotic melanoma, skin .a 2837 to 3694 16 to 877       862/883
(97 %)
18 diff
(98.0 %id)
BF303616 muscle, rhabdomyosarcoma .a 2873 to 3571 1 to 692       692/907
(76 %)
15 diff
(98.4 %id)
BF932998 nervous_tumor .a 2901 to 3228 328 to 1     Submitted on the opposite strand 328/333
(98 %)
0 diff
(100 %id)
BF933026 nervous_tumor .a 2901 to 3228 328 to 1     Submitted on the opposite strand 328/330
(99 %)
0 diff
(100 %id)
TI_154120430   .a 2937 to 3749 888 to 84   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 805/1021
(78 %)
11 diff
(99.0 %id)
AA034102.
matches multiple genes
uterus .a 2942 to 3098 1 to 155     also hits gene TMEM167B 155/158
(98 %)
4 diff
(97.5 %id)
DQ786287   .a 2943 to 3756 26 to 840   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 815/840
(97 %)
6 diff
(99.3 %id)
TI_154104100   .a 2974 to 3749 852 to 85   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 768/949
(80 %)
10 diff
(99.0 %id)
CA446265 Chondrosarcoma, Left Pubic Bone .a 2988 to 3749 775 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 757/758
(99 %)
7 diff
(99.1 %id)
CA418439 Chondrosarcoma Grade II, Left Pelvis .a 3019 to 3749 746 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 728/758
(96 %)
2 diff
(99.8 %id)
AI174253 schizophrenic brain S-11 frontal lobe .a 3042 to 3462 426 to 7       420/426
(98 %)
0 diff
(100 %id)
CN260631 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3051 to 3576 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
BE706051.
matches multiple genes
head_neck .a 3139 to 3350 214 to 1     also hits gene DDX12, LOC642846 214/214
(100 %)
8 diff
(96.3 %id)
TI_154137281   .a 3201 to 3749 636 to 88   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 549/550
(99 %)
9 diff
(98.4 %id)
AW249533 lung, small cell carcinoma .a 3205 to 3749 555 to 11   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 545/545
(100 %)
9 diff
(98.4 %id)
AA193356 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3236 to 3582 1 to 350       350/354
(98 %)
4 diff
(98.9 %id)
AI632422 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3246 to 3749 511 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 493/765
(64 %)
18 diff
(97.7 %id)
CR590809 Neuroblastoma Cot 25-normalized .a 3282 to 3771 1 to 490       490/490
(100 %)
0 diff
(100 %id)
BX332884 Neuroblastoma Cot 25-normalized .a 3282 to 3771 1 to 489   fully sequenced,   489/489
(100 %)
1 diff
(99.8 %id)
BF056629 fibrotheoma, ovary .a 3282 to 3749 483 to 16   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 468/468
(100 %)
10 diff
(97.9 %id)
BF513378   .a 3293 to 3749 474 to 18   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 457/457
(100 %)
1 diff
(99.8 %id)
AA424284 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3309 to 3707 1 to 397       397/397
(100 %)
7 diff
(98.3 %id)
AI949043 pooled germ cell tumors .a 3311 to 3752 447 to 5       443/447
(99 %)
0 diff
(100 %id)
AV693749 hepatocellular carcinoma .a 3314 to 3749 1 to 436   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 436/436
(100 %)
3 diff
(99.4 %id)
AW249747 lung, small cell carcinoma .a 3314 to 3750 448 to 12   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 437/437
(100 %)
5 diff
(98.9 %id)
AI948546 anaplastic oligodendroglioma, brain .a 3315 to 3749 435 to 1       435/435
(100 %)
2 diff
(99.6 %id)
AW576032.
matches multiple genes
lymph .a 3317 to 3749 451 to 18   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base), also hits gene ATP11A 434/436
(99 %)
16 diff
(96.4 %id)
AI138714 uterus .a 3319 to 3756 448 to 11   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 438/438
(100 %)
6 diff
(98.7 %id)
AI671376 Kidney .a 3324 to 3749 426 to 1       426/426
(100 %)
5 diff
(98.9 %id)
AA757867 pineal gland .a 3325 to 3749 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
AW467528 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 3342 to 3749 414 to 7       408/414
(98 %)
0 diff
(100 %id)
AA494304 colon .a 3346 to 3749 414 to 11   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 404/405
(99 %)
3 diff
(99.3 %id)
AW002625 pooled germ cell tumors .a 3355 to 3756 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AI342087 pooled germ cell tumors .a 3356 to 3750 424 to 30   AAA   395/401
(98 %)
0 diff
(100 %id)
AI866900 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 3358 to 3757 401 to 2       400/401
(99 %)
0 diff
(100 %id)
AI885564 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3359 to 3750 421 to 29   AAA   393/399
(98 %)
0 diff
(100 %id)
AI862199 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3360 to 3749 392 to 3       390/392
(99 %)
0 diff
(100 %id)
BE138729 adenocarcinoma, Pancreas .a 3360 to 3765 408 to 3       406/408
(99 %)
0 diff
(100 %id)
AA653212   .a 3380 to 3757 385 to 9       377/385
(97 %)
0 diff
(100 %id)
AI990502 pooled germ cell tumors .a 3381 to 3750 398 to 28   AAA   371/377
(98 %)
0 diff
(100 %id)
AW002421 pooled germ cell tumors .a 3391 to 3756 384 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 366/366
(100 %)
8 diff
(97.9 %id)
BE672052 pooled germ cell tumors .a 3391 to 3756 366 to 1       366/366
(100 %)
1 diff
(99.8 %id)
AA617784 lung, lung tumor .a 3399 to 3673 275 to 1       275/275
(100 %)
2 diff
(99.3 %id)
AA678423   .a 3410 to 3757 348 to 2       347/348
(99 %)
0 diff
(100 %id)
AA032090 uterus .a 3419 to 3729 312 to 1       312/312
(100 %)
6 diff
(98.1 %id)
BF930595 nervous_tumor .a 3423 to 3658 259 to 24     Submitted on the opposite strand 236/265
(89 %)
0 diff
(100 %id)
BF930600 nervous_tumor .a 3423 to 3662 260 to 21     Submitted on the opposite strand 240/266
(90 %)
0 diff
(100 %id)
AI569555 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3425 to 3750 356 to 31   AAA   326/332
(98 %)
0 diff
(100 %id)
BF156045 stomach .a 3440 to 3708 26 to 291       266/291
(91 %)
6 diff
(98.0 %id)
BI047756 stomach .a 3440 to 3708 268 to 1       268/268
(100 %)
5 diff
(98.2 %id)
BI048251 stomach .a 3440 to 3708 267 to 1       267/267
(100 %)
2 diff
(99.3 %id)
BF906687 stomach .a 3441 to 3676 249 to 15     Submitted on the opposite strand 235/250
(94 %)
0 diff
(100 %id)
BE937281 stomach .a 3443 to 3708 8 to 272       265/272
(97 %)
6 diff
(97.8 %id)
BF820639 kidney_tumor .a 3462 to 3754 10 to 300       291/302
(96 %)
12 diff
(96.1 %id)
BX332883 Neuroblastoma Cot 25-normalized .a 3462 to 3736 275 to 1   fully sequenced,   275/275
(100 %)
2 diff
(99.3 %id)
AI270182 colon, moderately-differentiated adenocarcinoma .a 3462 to 3749 295 to 8       288/295
(97 %)
0 diff
(100 %id)
AW879352 ovary .a 3475 to 3743 16 to 281       266/299
(88 %)
10 diff
(96.7 %id)
AA505529 breast .a 3480 to 3749 315 to 46   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 270/270
(100 %)
0 diff
(100 %id)
AW840198 leiomios .a 3488 to 3708 20 to 239       220/239
(92 %)
6 diff
(97.5 %id)
BI047652 stomach .a 3516 to 3708 192 to 1       192/192
(100 %)
5 diff
(97.4 %id)
AA973745 pooled germ cell tumors .a 3521 to 3750 233 to 4       230/233
(98 %)
0 diff
(100 %id)
AW419086 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 3535 to 3749 221 to 7       215/221
(97 %)
0 diff
(100 %id)
BX352916 Neuroblastoma Cot 10-normalized .a 3548 to 3750 1 to 203   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 203/203
(100 %)
0 diff
(100 %id)
EC541883.
matches multiple genes
Prostate .a 3556 to 3646 14 to 104     also hits gene DDX12, LOC642846 91/104
(87 %)
6 diff
(94.3 %id)
EC487222 Prostate .a 3571 to 3669 1 to 99       99/99
(100 %)
4 diff
(96.0 %id)
EC500851 Prostate .a 3573 to 3669 1 to 93       93/93
(100 %)
3 diff
(96.8 %id)
NM_152438.1   .b 1 to 3922 1 to 3922 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3922/3922
(100 %)
0 diff
(100 %id)
DW441112 Liver .b 3 to 374 9 to 380       372/380
(97 %)
7 diff
(98.2 %id)
DW447505 Liver .b 7 to 208 11 to 212       202/212
(95 %)
6 diff
(97.2 %id)
DW451352 Liver .b 7 to 374 11 to 378   tiling clone,   368/378
(97 %)
6 diff
(98.5 %id)
DW410711 Liver .b 8 to 333 9 to 332       324/332
(97 %)
6 diff
(98.2 %id)
DW467567 Liver .b 8 to 346 9 to 345       337/345
(97 %)
8 diff
(97.7 %id)
DC353657 brain .b 16 to 454 1 to 442       442/442
(100 %)
3 diff
(99.4 %id)
DC388741 small intestine .b 16 to 580 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC309634 cerebellum .b 19 to 564 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
DR002277 fetal brain .b 23 to 723 1 to 701       701/701
(100 %)
6 diff
(99.2 %id)
DR001928 fetal brain .b 24 to 720 7 to 703       697/703
(99 %)
6 diff
(99.2 %id)
BG771847 testis .b 30 to 549 1 to 521       521/521
(100 %)
8 diff
(98.5 %id)
BC011264 Placenta, choriocarcinoma .b 36 to 3922 1 to 3887 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3887/3887
(100 %)
0 diff
(100 %id)
DA858113 placenta .b 36 to 590 2 to 559   capped   558/558
(100 %)
4 diff
(99.3 %id)
DA918742 small intestine .b 36 to 609 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BU500749   .b 39 to 839 5 to 806       802/943
(85 %)
16 diff
(98.4 %id)
BU500190   .b 39 to 895 12 to 869       858/934
(91 %)
12 diff
(98.8 %id)
CD689059 normal nasopharynx .b 40 to 662 20 to 642       623/642
(97 %)
10 diff
(98.5 %id)
TI_57235278   .b 41 to 609 26 to 604       579/729
(79 %)
15 diff
(98.0 %id)
BX457150 thymus .b 46 to 878 1 to 835       835/835
(100 %)
6 diff
(99.3 %id)
BI908072 leukocyte .b 47 to 609 1 to 574   available from MGC,   574/699
(82 %)
15 diff
(97.9 %id)
DB149040 thymus .b 52 to 616 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DC405585 thymus .b 57 to 635 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
AL135665 melanoma (MeWo cell line) .b 58 to 583 1 to 526       526/529
(99 %)
1 diff
(99.9 %id)
CN260629 embryonic stem cells, cell lines H1, H7, andH9 .b 66 to 731 1 to 665       665/666
(99 %)
2 diff
(99.7 %id)
AL560866 B cells from Burkitt lymphoma .b 69 to 1043 1 to 969       969/969
(100 %)
7 diff
(99.3 %id)
DR001664 fetal brain .b 76 to 269 9 to 202       194/202
(96 %)
6 diff
(97.1 %id)
AL704272 human skeletal muscle .b 81 to 705 1 to 627       627/627
(100 %)
14 diff
(97.8 %id)
CF143707 lymph .b 94 to 423 1 to 330       330/330
(100 %)
7 diff
(97.9 %id)
TI_154175204   .b 100 to 557 77 to 535       459/462
(99 %)
23 diff
(95.1 %id)
BF912674 uterus_tumor .b 111 to 641 532 to 3     Submitted on the opposite strand 530/532
(99 %)
1 diff
(99.9 %id)
BX437505 thymus .b 132 to 886 82 to 837       756/837
(90 %)
18 diff
(97.9 %id)
DB285094 uterus .b 222 to 769 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BY795236 eye .b 241 to 849 1 to 609       609/609
(100 %)
0 diff
(100 %id)
TI_1948150982   .b 251 to 895 126 to 771       646/1359
(47 %)
21 diff
(98.5 %id)
TI_1948150983   .b 251 to 895 125 to 770       646/1192
(54 %)
24 diff
(98.0 %id)
TI_1948151247   .b 251 to 901 129 to 779       651/1427
(45 %)
19 diff
(98.7 %id)
TI_1948151248   .b 251 to 1127 123 to 1003       881/1151
(76 %)
27 diff
(97.7 %id)
TI_1948151522   .b 251 to 941 125 to 817       693/1394
(49 %)
23 diff
(98.4 %id)
TI_1948151523   .b 251 to 1122 124 to 1001       878/1172
(74 %)
20 diff
(98.3 %id)
CN260636 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 256 to 706 1 to 451       451/451
(100 %)
0 diff
(100 %id)
CN260643 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 276 to 885 8 to 617       610/617
(98 %)
6 diff
(99.1 %id)
BE382424 brain, neuroblastoma .b 308 to 700 280 to 672       393/672
(58 %)
8 diff
(98.9 %id)
CN260632 embryonic stem cells, DMSO-treated H9 cellline .b 477 to 879 1 to 403       403/403
(100 %)
1 diff
(99.8 %id)
BE279644 choriocarcinoma, placenta .b 633 to 1260 1 to 630       630/630
(100 %)
10 diff
(98.5 %id)
BE698202.
matches multiple genes
uterus_tumor .b 728 to 836 116 to 8     also hits gene DDX12, LOC642846 109/123
(88 %)
0 diff
(100 %id)
AI910052 breast .b 823 to 1063 1 to 242       242/242
(100 %)
6 diff
(97.6 %id)
BF913075 uterus_tumor .b 827 to 986 1 to 160       160/160
(100 %)
5 diff
(96.9 %id)
CN260637 embryonic stem cells, cell lines H1, H7, andH9 .b 833 to 1295 160 to 622       463/622
(74 %)
6 diff
(99.1 %id)
BX370633   .b 840 to 1739 1 to 898       898/899
(99 %)
14 diff
(98.5 %id)
BX490233   .b 907 to 1508 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BQ214770 melanotic melanoma, skin .b 916 to 1601 1 to 698       695/925
(75 %)
18 diff
(98.1 %id)
BF803244 colon_ins .b 1007 to 1533 1 to 527       527/527
(100 %)
3 diff
(99.5 %id)
DR007928.
matches multiple genes
pooled .b 1128 to 1441 314 to 1     Submitted on the opposite strand, also hits gene DDX12, LOC642846 314/314
(100 %)
5 diff
(98.5 %id)
BM479408 eye, retinoblastoma .b 1187 to 2113 12 to 950       939/1043
(90 %)
23 diff
(97.8 %id)
BG479641 choriocarcinoma, placenta .b 1221 to 1981 1 to 758       758/759
(99 %)
7 diff
(99.1 %id)
DA890636 rectum .b 1226 to 1732 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
ES307534.
matches multiple genes
beard hair, skin .b 1289 to 1491 1 to 203     also hits gene LOC642846 203/203
(100 %)
6 diff
(97.1 %id)
AW176401.
matches multiple genes
colon .b 1384 to 1799 1 to 416     also hits gene LOC642846 416/416
(100 %)
6 diff
(98.6 %id)
BF765250.
matches multiple genes
colon_est .b 1459 to 1732 1 to 274     also hits gene LOC642846 274/274
(100 %)
2 diff
(99.3 %id)
BE797011 lung, small cell carcinoma .b 1519 to 2303 1 to 782       782/878
(89 %)
8 diff
(99.1 %id)
BE792473 lung, small cell carcinoma .b 1530 to 2375 1 to 840       840/945
(88 %)
23 diff
(97.6 %id)
BQ690982 ductal carcinoma, cell line, Pancreas .b 1671 to 2452 1 to 784       784/881
(88 %)
10 diff
(98.9 %id)
BQ687906 ductal carcinoma, cell line, Pancreas .b 1671 to 2574 1 to 907       907/940
(96 %)
11 diff
(98.9 %id)
BF763833 colon_est .b 1709 to 2153 19 to 463       445/463
(96 %)
9 diff
(98.1 %id)
BF763837 colon_est .b 1709 to 2114 16 to 419       404/419
(96 %)
9 diff
(97.9 %id)
BE265018 lung, small cell carcinoma .b 1728 to 2391 1 to 661       661/730
(90 %)
10 diff
(98.7 %id)
BE546916 cervical carcinoma cell line, cervix .b 1739 to 2444 1 to 705       705/801
(88 %)
20 diff
(97.6 %id)
BU151363 brain, neuroblastoma, cell line .b 1759 to 2639 1 to 881       881/926
(95 %)
13 diff
(98.6 %id)
BG116886 duodenal adenocarcinoma, cell line, small intestine .b 1762 to 2512 12 to 765       752/962
(78 %)
15 diff
(98.5 %id)
BE263643 lung, small cell carcinoma .b 1775 to 2205 1 to 431       431/431
(100 %)
1 diff
(99.8 %id)
BF764782 colon_est .b 1812 to 2156 1 to 345       345/345
(100 %)
8 diff
(97.7 %id)
BF763759 colon_est .b 1823 to 2210 399 to 12     Submitted on the opposite strand 388/399
(97 %)
2 diff
(99.5 %id)
BF763765 colon_est .b 1830 to 2201 407 to 35     Submitted on the opposite strand 377/407
(92 %)
2 diff
(99.6 %id)
BQ712322 Spleen .b 1836 to 2713 8 to 886       879/917
(95 %)
31 diff
(96.7 %id)
AA580769 bulk germ cell seminoma .b 1880 to 2014 1 to 135       135/139
(97 %)
5 diff
(96.5 %id)
BG830008 epithelioid carcinoma cell line, Pancreas .b 1905 to 2582 1 to 676       676/677
(99 %)
7 diff
(99.0 %id)
U25934   .b 1959 to 2231 273 to 1       273/273
(100 %)
2 diff
(99.3 %id)
BU190033 leiomyosarcoma, uterus .b 2086 to 2452 1 to 369       369/874
(42 %)
8 diff
(99.1 %id)
AW250383 lung, small cell carcinoma .b 2100 to 2658 19 to 577     Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 559/577
(96 %)
8 diff
(98.7 %id)
BE296982 muscle, rhabdomyosarcoma .b 2119 to 2779 1 to 672       672/823
(81 %)
24 diff
(97.1 %id)
BI118065 lung, small cell carcinoma .b 2128 to 2639 1 to 514       514/824
(62 %)
13 diff
(98.5 %id)
TI_1210517298   .b 2149 to 2530 400 to 19       382/828
(46 %)
5 diff
(99.4 %id)
DY654510.
matches multiple genes
pooled .b 2163 to 2517 355 to 1   tiling clone, also hits gene LOC642846 355/359
(98 %)
3 diff
(99.2 %id)
DY654688 pooled .b 2163 to 2520 358 to 1       358/359
(99 %)
7 diff
(98.1 %id)
DY655162 pooled .b 2163 to 2498 337 to 1       337/338
(99 %)
5 diff
(98.6 %id)
DY654687 pooled .b 2187 to 2548 1 to 362       362/362
(100 %)
28 diff
(92.3 %id)
TI_1948150985   .b 2193 to 3167 1098 to 125       974/1472
(66 %)
21 diff
(98.6 %id)
TI_1948151525   .b 2193 to 3167 1103 to 126       978/1434
(68 %)
24 diff
(98.4 %id)
DY655161 pooled .b 2195 to 2565 1 to 370       370/370
(100 %)
25 diff
(93.3 %id)
TI_1948151249   .b 2295 to 3167 993 to 124       870/1318
(66 %)
14 diff
(99.0 %id)
TI_1948151524   .b 2302 to 3167 984 to 125       860/1308
(65 %)
12 diff
(99.1 %id)
TI_1948151250   .b 2305 to 3167 987 to 125       863/1537
(56 %)
6 diff
(99.7 %id)
BM795044 Ascites, stomach .b 2311 to 2609 1 to 299       299/299
(100 %)
0 diff
(100 %id)
BM706959 eye, optic nerve .b 2375 to 2676 1 to 302     Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 302/302
(100 %)
5 diff
(98.4 %id)
TI_1948150984   .b 2452 to 3167 847 to 129       719/1339
(53 %)
17 diff
(98.8 %id)
BY993889   .b 2623 to 3214 25 to 616       592/616
(96 %)
8 diff
(98.8 %id)
BE886718 leiomyosarcoma, uterus .b 2738 to 3479 1 to 740       740/844
(87 %)
23 diff
(97.3 %id)
AW818974.
matches multiple genes
stomach .b 2789 to 2963 20 to 190   tiling clone, also hits gene DDX12, LOC642846 171/190
(90 %)
6 diff
(96.9 %id)
BE937556.
matches multiple genes
stomach .b 2789 to 2963 20 to 190     also hits gene DDX12, LOC642846 171/190
(90 %)
6 diff
(96.9 %id)
BQ049975 lymph, lymphoma, cell line .b 2814 to 3635 1 to 838       838/976
(85 %)
24 diff
(97.6 %id)
CN260639 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2823 to 3194 1 to 372       372/372
(100 %)
2 diff
(99.5 %id)
AL560837 B cells from Burkitt lymphoma .b 2849 to 3895 1037 to 1       1037/1046
(99 %)
19 diff
(98.2 %id)
CR987767 T-Lymphocytes .b 2882 to 3558 1 to 676       676/676
(100 %)
3 diff
(99.6 %id)
BX457149 thymus .b 3001 to 3862 861 to 1       861/861
(100 %)
8 diff
(99.1 %id)
AW250979 lung, small cell carcinoma .b 3490 to 3922 443 to 11   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 433/433
(100 %)
10 diff
(97.7 %id)
BU728275 eye, optic nerve .b 3496 to 3922 445 to 19   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
BX403981 neuroblastoma .c 1 to 1025 1 to 1015   tiling clone,   1015/1101
(92 %)
20 diff
(98.2 %id)
BX411789 neuroblastoma .c 3501 to 3788 286 to 1   tiling clone,   286/289
(98 %)
17 diff
(94.2 %id)
BC111733.
matches multiple genes
PCR rescued clones .d 1 to 3079 1 to 3079 T556V L557P R558Q Q567E S665I ... tiling clone, This clone was ignored, also hits gene DDX12 3079/3079
(100 %)
31 diff
(99.0 %id)
NM_030653.3   .d 1 to 3927 1 to 3927 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3927/3927
(100 %)
0 diff
(100 %id)
U33833   .d 74 to 3167 1 to 3094 Q567E tiling clone,   3094/3096
(99 %)
7 diff
(99.8 %id)
U75967   .d 111 to 3927 1 to 3817 Q567E V858I tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3817/3817
(100 %)
10 diff
(99.8 %id)
BE895027 melanotic melanoma, skin .d 2092 to 2866 1 to 778       775/801
(96 %)
33 diff
(95.9 %id)
BF684170 leiomyosarcoma cell line, uterus .d 2212 to 2866 1 to 672       664/780
(85 %)
38 diff
(95.2 %id)
BQ060802 lymph, lymphoma, cell line .d 2216 to 3087 1 to 874       874/979
(89 %)
17 diff
(98.3 %id)
BQ062341 lymph, lymphoma, cell line .d 2216 to 3091 1 to 893   tiling clone,   893/1005
(88 %)
27 diff
(97.4 %id)
BM745571 Ascites, stomach .d 2274 to 2765 1 to 492       492/492
(100 %)
2 diff
(99.6 %id)
CF145432 CNCAP(3)T-225 cell line, Prostate .d 2329 to 3052 8 to 731       724/731
(99 %)
9 diff
(98.8 %id)
TI_154177651   .d 2329 to 3071 68 to 810       743/744
(99 %)
4 diff
(99.5 %id)
BE799660.
matches multiple genes
lung, small cell carcinoma .d 2339 to 3169 31 to 857   tiling clone, also hits gene LOC642846 827/986
(83 %)
24 diff
(97.6 %id)
CR617012 thymus .d 2419 to 3899 1 to 1481   tiling clone,   1481/1481
(100 %)
0 diff
(100 %id)
BX436746 thymus .d 2419 to 3118 1 to 693   fully sequenced,   693/693
(100 %)
3 diff
(99.6 %id)
AW247649 lung, small cell carcinoma .d 2517 to 3026 10 to 519     Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 510/519
(98 %)
9 diff
(98.3 %id)
BI061715 uterus_tumor .d 2576 to 3049 1 to 474       474/474
(100 %)
6 diff
(98.8 %id)
BQ069443 brain, neuroblastoma, cell line .d 2592 to 3415 21 to 855       835/1153
(72 %)
35 diff
(97.0 %id)
BX436745 thymus .d 3088 to 3899 813 to 1   fully sequenced,   813/813
(100 %)
9 diff
(98.9 %id)
AW247905 lung, small cell carcinoma .d 3771 to 3927 167 to 11   AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 157/158
(99 %)
8 diff
(95.0 %id)
BI460107 testis .e 1 to 692 1 to 700       700/882
(79 %)
24 diff
(97.3 %id)
BI461475 testis .e 2 to 624 1 to 622       622/622
(100 %)
4 diff
(99.4 %id)
BC050069 testis .e 6 to 3722 1 to 3717 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3717/3717
(100 %)
1 diff
(100.0 %id)
NM_004399.2   .f 1 to 3777 1 to 3777 exact RefSeq, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3777/3777
(100 %)
0 diff
(100 %id)
X99583   .f 54 to 3777 15 to 3737 I39S V644G V645G E646G F647V ... tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 3725/3737
(99 %)
11 diff
(99.8 %id)
BC047317 Blood, adult leukocytes .g 1 to 4260 6 to 4047 exact tiling clone, available from MGC, AAA Suspected internal deletion, possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 4047/4047
(100 %)
0 diff
(100 %id)
U75969   .h 1 to 2772 1 to 2772 Q292E tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 2772/2772
(100 %)
8 diff
(99.8 %id)
U75968   .i 1 to 4178 5 to 4182 Q245E R349C tiling clone, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 4182/4182
(100 %)
10 diff
(99.8 %id)
CN260630 embryonic stem cells, cell lines H1, H7, andH9 .i 376 to 1037 1 to 662       662/662
(100 %)
0 diff
(100 %id)
CX872142 embryonic stem .i 2682 to 3431 1 to 750   tiling clone,   750/750
(100 %)
1 diff
(99.9 %id)
BE799797 lung, small cell carcinoma .i 2709 to 3511 36 to 834       799/834
(95 %)
19 diff
(97.8 %id)
CX752546 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 3066 to 3778 1 to 711   tiling clone, Submitted on the opposite strand 711/711
(100 %)
3 diff
(99.6 %id)
DB267051 uterus .j 1 to 545 2 to 546   tiling clone, capped   545/545
(100 %)
1 diff
(99.9 %id)
BX331255 Neuroblastoma Cot 10-normalized .j 4 to 886 1 to 881   tiling clone,   881/881
(100 %)
1 diff
(99.9 %id)
DN999806   .j 844 to 1460 9 to 623   tiling clone,   615/623
(98 %)
4 diff
(99.4 %id)
AK297607 brain .k 1 to 1561 1 to 1561   tiling clone,   1561/1561
(100 %)
0 diff
(100 %id)
CN260645 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 1407 to 2058 1 to 652   tiling clone,   652/652
(100 %)
1 diff
(99.9 %id)
DW416065 Liver .l 1 to 302 9 to 310   tiling clone,   302/310
(97 %)
6 diff
(98.1 %id)
BC148224 PCR rescued clones .l 16 to 1773 1 to 1760 H293K D294K P296F G297Q T298E tiling clone,   1760/1765
(99 %)
5 diff
(99.8 %id)
DW412383 Liver .l 24 to 341 9 to 324       316/324
(97 %)
6 diff
(98.2 %id)
DW419764 Liver .l 24 to 319 9 to 302       294/302
(97 %)
6 diff
(98.1 %id)
BX332696 Neuroblastoma Cot 25-normalized .l 45 to 989 27 to 971       945/979
(96 %)
21 diff
(97.9 %id)
BX332695 Neuroblastoma Cot 25-normalized .l 1591 to 2566 974 to 1   tiling clone,   974/977
(99 %)
38 diff
(96.2 %id)
AK303139 thymus .m 1 to 1719 1 to 1719 exact tiling clone,   1719/1719
(100 %)
9 diff
(99.5 %id)
AK024117 whole embryo, mainly body .m 888 to 2602 1 to 1715   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 1715/1715
(100 %)
9 diff
(99.5 %id)
AU120243.
matches multiple genes
whole embryo, mainly body .m 889 to 1667 2 to 781   capped Suspected internal deletion, this clone was ignored, also hits gene EPC1 780/780
(100 %)
18 diff
(97.7 %id)
BG012338.
matches multiple genes
placenta_normal .m 1368 to 1575 1 to 207   tiling clone, also hits gene DDX12 207/207
(100 %)
13 diff
(93.8 %id)
BQ053959 blood, natural killer cells, cell line .n 1 to 957 34 to 1011 E163G N169D G181S E183G A184S ... tiling clone,   978/1108
(88 %)
35 diff
(96.9 %id)
AL047846 uterus .o 1 to 582 30 to 611   tiling clone,   582/612
(95 %)
9 diff
(98.6 %id)
BF871117 lung_tumor .o 394 to 731 1 to 339   tiling clone,   339/350
(96 %)
11 diff
(96.9 %id)
BU859051 ovary, teratocarcinoma, cell line .p 1 to 879 1 to 882 R172Q R173E R176X E177R E178R ... tiling clone,   882/883
(99 %)
9 diff
(99.0 %id)
DB227200 trachea .q 1 to 582 2 to 583   tiling clone, capped   582/582
(100 %)
0 diff
(100 %id)
CN284468 embryonic stem cells, cell lines H1, H7, andH9 .q 494 to 803 1 to 313   tiling clone,   313/313
(100 %)
6 diff
(98.1 %id)
CV570787 cornea, eye .q 677 to 1294 1 to 618   tiling clone,   618/618
(100 %)
0 diff
(100 %id)
AK021703 whole embryo, mainly head .q 917 to 2742 1 to 1825 exact tiling clone, available from FLJ,   1825/1825
(100 %)
11 diff
(99.4 %id)
AU118789 whole embryo, mainly head .q 918 to 1639 2 to 724   capped   723/723
(100 %)
7 diff
(99.1 %id)
BQ370525 placenta_normal .q 1625 to 1976 1 to 350   tiling clone,   350/363
(96 %)
10 diff
(97.3 %id)
BJ991618 hepatoblastoma .q 1807 to 2214 1 to 408   tiling clone,   408/410
(99 %)
5 diff
(98.8 %id)
AW571709 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .q 2155 to 2744 589 to 1   tiling clone,   589/590
(99 %)
10 diff
(98.4 %id)
DB349774 trachea .q 2194 to 2742 549 to 1       549/549
(100 %)
3 diff
(99.5 %id)
AU145272 whole embryo, mainly head .q 2266 to 2742 475 to 1       475/508
(93 %)
18 diff
(96.5 %id)
AA780912   .q 2267 to 2757 489 to 1   tiling clone,   489/489
(100 %)
9 diff
(98.2 %id)
AA599656   .q 2378 to 2743 365 to 1   tiling clone,   365/365
(100 %)
4 diff
(99.0 %id)
DC390663 Spleen .r 1 to 561 1 to 561 exact tiling clone,   561/561
(100 %)
0 diff
(100 %id)
BI116165 lung, small cell carcinoma .s 1 to 354 1 to 360   tiling clone,   360/581
(61 %)
13 diff
(97.8 %id)
BC012834 Lung, small cell carcinoma .s 3 to 1185 1 to 1183 R27H C122R tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (24/24 A in genome downstream of last aligned base) 1183/1183
(100 %)
7 diff
(99.5 %id)
BM756871.
matches multiple genes
Ascites, stomach .t 1 to 458 1 to 458   tiling clone, also hits gene LOC642846 458/458
(100 %)
13 diff
(97.2 %id)
BM756886.
matches multiple genes
Ascites, stomach .t 1 to 512 1 to 512   tiling clone, also hits gene LOC642846 512/512
(100 %)
13 diff
(97.5 %id)
BM771525.
matches multiple genes
Ascites, stomach .t 1 to 428 1 to 428     also hits gene LOC642846 428/428
(100 %)
11 diff
(97.5 %id)
BE148622.
matches multiple genes
head_neck .t 462 to 592 132 to 5   tiling clone, Submitted on the opposite strand, also hits gene DDX12, LOC642846 128/137
(93 %)
5 diff
(96.4 %id)
CN260638 embryonic stem cells, DMSO-treated H9 cellline .u 1 to 613 1 to 613 exact tiling clone,   613/614
(99 %)
1 diff
(99.9 %id)
AW205173.
matches multiple genes
  .va-u 1 to 382 404 to 13 Q39K W51S M78T tiling clone, AAA also hits gene bleychu, kloblabu 387/387
(100 %)
5 diff
(98.8 %id)
CR994358 T-Lymphocytes .vb-u 1 to 654 1 to 654 R96H tiling clone,   654/665
(98 %)
4 diff
(99.4 %id)
BE145702 head_neck .vc 1 to 293 291 to 1   tiling clone, Submitted on the opposite strand 291/291
(100 %)
0 diff
(100 %id)
AW139528   .vc 136 to 526 16 to 406   tiling clone, Submitted on the opposite strand 391/406
(96 %)
1 diff
(99.8 %id)
CN260642 embryonic stem cells, cell lines H1, H7, andH9 .vc 145 to 746 1 to 601   tiling clone,   601/601
(100 %)
1 diff
(99.9 %id)
CN260641 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vc 619 to 1361 1 to 744   tiling clone,   744/753
(98 %)
11 diff
(98.6 %id)
CN266106 embryonic stem cells, cell lines H1, H7, andH9 .vc 946 to 1547 9 to 610   tiling clone,   602/610
(98 %)
6 diff
(99.1 %id)
BP423641 small intestine .vc 1408 to 1896 1 to 490 exact tiling clone, Submitted on the opposite strand 490/490
(100 %)
1 diff
(99.8 %id)
DB205895 trachea .vd 1 to 481 2 to 481 exact tiling clone, capped   480/480
(100 %)
1 diff
(99.8 %id)
CN260640 embryonic stem cells, DMSO-treated H9 cellline .ve 1 to 439 1 to 438 exact tiling clone,   438/438
(100 %)
5 diff
(98.9 %id)
U25935   .vf-u 1 to 159 1 to 159 exact tiling clone,   159/159
(100 %)
1 diff
(99.4 %id)
BM974087 lung Gene DDX11, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BX646740 Liver Gene DDX11, variant not shown         This clone was ignored    
BX646741 Liver Gene DDX11, variant not shown       AAA This clone was ignored    
AV682946 hepatocellular carcinoma Gene DDX11, variant not shown         Suspected internal deletion, this clone was ignored    
DC339099 subthalamic nucleus Gene DDX11, variant not shown         Suspected internal deletion, this clone was ignored    
DW466248 Liver Gene DDX11, variant not shown         This clone was ignored    
DN997935 breast cancer, Mammary gland (cancer tissue) Gene DDX11, variant not shown         Suspected internal deletion, this clone was ignored    
BC001591 Colon, adenocarcinoma Gene DDX11, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
DC340395 thalamus Gene DDX11, variant not shown         This clone was ignored    
AA261914 germinal center B cell Gene DDX11, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AA262551 germinal center B cell Gene DDX11, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AA767354 germinal center B cell Gene DDX11, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BE292900 adenocarcinoma cell line, colon Gene DDX11, variant not shown       available from MGC, Suspected internal deletion, this clone was ignored    
BE794815 lung, small cell carcinoma Gene DDX11, variant not shown         Suspected internal deletion, this clone was ignored    
BG910430 anaplastic oligodendroglioma with 1p/19qloss, brain Gene DDX11, variant not shown         This clone was ignored    
TI_149291472   Gene DDX11, variant not shown       AAA Suspected internal deletion, suspected internal deletion, this clone was ignored    
TI_154166379   Gene DDX11, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb-u, .vc, .vd, .ve, .vf-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI